WYNNEWOOD, PA
4 risk indicators measuring financial stability and operational resilience
Sign in with your work email to view Tuckman-Chang indicators
Sign In — Free (10 views/day)LANKENAU INSTITUTE FOR MEDICAL RESEARCH, founded in 1981, is a community nonprofit that reported $10.0M in total revenue in fiscal year 2024. Revenue decreased 7% compared to the prior year. Expenses of $17.7M exceeded revenue, resulting in a 77% operating deficit.
OUR MISSION IS TO ADVANCE HUMAN HEALTH AND WELL BEING THROUGH RESEARCH, TO IMPROVE THE DETECTION & TREATMENT OF DISEASE, TO RAPIDLY TRANSFER NEW TECHNOLOGY TO THE CLINIC, AND TO TRAIN THE NEXT GENERATION OF SCIENTISTS & PHYSICIANS.
Basic Research LIMR Basic Research focuses on the advancement of knowledge for various diseases and conditions. In conjunction with LIMR's core research programs in cancer and cardiovascular disease...
Basic Research LIMR Basic Research focuses on the advancement of knowledge for various diseases and conditions. In conjunction with LIMR's core research programs in cancer and cardiovascular disease, LIMR investigators also study arthritis, diabetes, lupus, infectious disease, neurological disorders, gastrointestinal disease and regenerative medicine, all with the goal of improving health and well-being.
Clinical Research LIMR Clinical Research is conducted primarily in oncology and cardiology but also includes other diseases and disorders. This means patients and participants have access to...
Clinical Research LIMR Clinical Research is conducted primarily in oncology and cardiology but also includes other diseases and disorders. This means patients and participants have access to state-of-the-art clinical trials and new treatments before they become available to the general public. This allows patients to be more active in their health care.
New Technology / Innovations / Other LIMR has initiated a unique hybrid mix of knowledge-based academic culture with invention-based entrepreneurial culture. It is called an ACAPRENEURIAL strategy...
New Technology / Innovations / Other LIMR has initiated a unique hybrid mix of knowledge-based academic culture with invention-based entrepreneurial culture. It is called an ACAPRENEURIAL strategy. To date, more than 15 biomedical start-up companies have incubated in LIMR side-by-side with our research laboratories.
Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency
Sign in to view Trantor Score and financial metrics
Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)
Sign In — Free (10 views/day)| 2024 | 2023 | Change | |
|---|---|---|---|
| Revenue | $9,978,219 | $10,729,900 | -0.1% |
| Expenses | $17,707,487 | $19,922,017 | -0.1% |
| Net Income | $-7,729,268 | $-9,192,117 | -0.2% |
Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics
Financial Distress Indicator
Liquidity & Cash Position
Sign in to view all financial metrics
Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics
Sign In| Name | Title | Hours/Week | Role | Reportable Comp | Other Comp | Total |
|---|---|---|---|---|---|---|
| JOHN J LYNCH III | EX-OFFICIO TRUSTEE | 1.0 |
Director
|
$0 | $691,538 | $3,302,622 |
| KATHLEEN GALBRAITH | EX-OFFICIO TRUSTEE | 1.0 |
Director
|
$0 | $143,159 | $1,045,672 |
| PATRICK ROSS JR | EX-OFFICIO TRUSTEE | 1.0 |
Director
|
$0 | $53,304 | $993,327 |
| JOSEPH GOBERN | EX-OFFICIO TRUSTEE | 1.0 |
Director
|
$0 | $39,310 | $713,784 |
| PAUL COADY | EX-OFFICIO TRUSTEE | 1.0 |
Director
|
$0 | $39,402 | $574,455 |
| GEORGE C PRENDERGAST | PRESIDENT & EX-OFFICIO TRUSTEE | 40.0 |
Officer
Director
|
$519,153 | $49,788 | $568,941 |
| SCOTT DESSAIN | ASSOC. PROF / HAT DIR | 40.0 |
Highest
|
$229,403 | $43,795 | $273,198 |
| ELLEN HEBER-KATZ | PROFESSOR | 40.0 |
Highest
|
$191,650 | $31,541 | $223,191 |
| MELVIN REICHMAN | SENIOR INVESTIGATOR | 40.0 |
Highest
|
$176,843 | $34,597 | $211,440 |
| PETER R KOWEY | TRUSTEE | 1.0 |
Director
|
$0 | $29,440 | $204,146 |
| SAMUEL DIIANNI | TREASURER | 40.0 |
Officer
|
$190,178 | $12,255 | $202,433 |
| Matthew Finley | VICE PRESIDENT | 40.0 |
Officer
|
$163,218 | $21,763 | $184,981 |
| JAMES MULLIN | PROFESSOR | 40.0 |
Highest
|
$163,122 | $11,322 | $174,444 |
| SUSAN GILMOUR | PROFESSOR | 40.0 |
Highest
|
$161,047 | $9,314 | $170,361 |
| PAUL B GILMAN | TRUSTEE | 1.0 |
Director
|
$153,950 | $0 | $153,950 |
| JOHN WELLENBACH | SECRETARY | 40.0 |
Officer
|
$122,995 | $29,345 | $152,340 |
| Alfred W Putnam Jr | EX-OFFICIO TRUSTEE | 1.0 |
Director
|
$0 | $0 | $0 |
| ALICE D CHASE | TRUSTEE | 1.0 |
Director
|
$0 | $0 | $0 |
| ELIZABETH WILKINS | TRUSTEE | 1.0 |
Director
|
$0 | $0 | $0 |
| I WISTAR MORRIS | TRUSTEE | 1.0 |
Director
|
$0 | $0 | $0 |
| JONATHAN CHARLES FOX | TRUSTEE | 1.0 |
Director
|
$0 | $0 | $0 |
| LAWRENCE LIVORNESE | EX-OFFICIO TRUSTEE | 1.0 |
Director
|
$0 | $0 | $0 |
| PETER H HAVENS | CHAIRMAN & TRUSTEE | 1.0 |
Officer
Director
|
$0 | $0 | $0 |
| SARA SENIOR | TRUSTEE | 1.0 |
Director
|
$0 | $0 | $0 |
| AMBER SALZMAN | TRUSTEE | 1.0 |
Director
|
$0 | $0 | $0 |
| KAREN GOTTING-SMITH | Trustee | 1.0 |
Director
|
$0 | $0 | $0 |
| LEILA GORDON | TRUSTEE | 1.0 |
Director
|
$0 | $0 | $0 |
| STEVEN HIGGINS | EX-OFFICIO TRUSTEE | 1.0 |
Director
|
$0 | $0 | $0 |
| Year | Revenue | Expenses | Assets | Net Income |
|---|---|---|---|---|
| 2025 | $9,978,219 | $17,707,487 | $13,804,415 | $-7,729,268 |
| 2024 | No data | No data | No data | No data |
| 2023 | $12,208,295 | $19,218,522 | $17,942,853 | $-7,010,227 |
| 2022 | $11,705,452 | $18,256,170 | $20,445,147 | $-6,550,718 |
| 2022 | $11,705,452 | $18,256,170 | $20,445,147 | $-6,550,718 |
| 2021 | $9,583,407 | $16,522,744 | $22,402,224 | $-6,939,337 |
| 2020 | $9,109,367 | $17,253,320 | $8,021,343 | $-8,143,953 |
| 2019 | $8,608,981 | $15,814,624 | $5,501,934 | $-7,205,643 |
| 2018 | $9,335,905 | $16,297,221 | $5,830,076 | $-6,961,316 |
Compare LANKENAU INSTITUTE FOR MEDICAL RESEARCH with other nonprofits in Pennsylvania and across the country.